Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 21799153)

Published in Circ Res on July 28, 2011

Authors

Daniela Malan1, Stephanie Friedrichs, Bernd K Fleischmann, Philipp Sasse

Author Affiliations

1: Institute of Physiology I, Life & Brain Center, University of Bonn, Germany.

Articles citing this

Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol (2012) 2.24

Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ Res (2013) 1.27

Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias. J Clin Invest (2013) 1.17

Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. Cell Calcium (2013) 1.07

The arrhythmogenic consequences of increasing late INa in the cardiomyocyte. Cardiovasc Res (2013) 1.03

Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J Physiol (2013) 1.02

Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening. Stem Cell Res Ther (2013) 1.01

Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome. PLoS One (2013) 0.96

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives. J Interv Card Electrophysiol (2013) 0.94

Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev (2013) 0.89

Induced pluripotent stem cells and their potential for basic and clinical sciences. Curr Cardiol Rev (2013) 0.88

Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells. Stem Cell Reports (2014) 0.88

Induced pluripotent stem cells for regenerative medicine. Annu Rev Biomed Eng (2014) 0.88

Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies. Appl Clin Genet (2013) 0.87

The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients. PLoS One (2013) 0.85

Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes. Cardiovasc Res (2015) 0.85

Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells. PLoS One (2013) 0.85

Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function. Circ Arrhythm Electrophysiol (2016) 0.84

3D-culture system for heart regeneration and cardiac medicine. Biomed Res Int (2013) 0.84

Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells. PLoS One (2014) 0.82

Modelling human channelopathies using induced pluripotent stem cells: a comprehensive review. Stem Cells Int (2013) 0.82

Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering. Regen Med Res (2013) 0.82

A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol (2014) 0.81

Embryonic type Na(+) channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome. Sci Rep (2016) 0.81

Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling. Stem Cell Rev (2015) 0.79

Prospective in vitro models of channelopathies and cardiomyopathies. Stem Cells Int (2012) 0.79

Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction. Basic Res Cardiol (2016) 0.79

Human induced pluripotent stem cell for modeling cardiovascular diseases. Regen Med Res (2014) 0.77

Chemical genetics and its potential in cardiac stem cell therapy. Br J Pharmacol (2013) 0.77

Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? Ann Palliat Med (2012) 0.77

Electrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration. IEEE Rev Biomed Eng (2015) 0.77

Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes. Biochim Biophys Acta (2015) 0.76

Current technology in the diagnosis of developmentally related lung disorders. Neonatology (2012) 0.76

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease. Stem Cell Rev (2015) 0.76

Patch clamp apply in cardiomyocytes derived from patient's iPS cells for individual anticancer therapy. Int J Clin Exp Med (2014) 0.76

Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. Sci Rep (2017) 0.76

Non-Invasive Acoustical sensing of Drug-Induced Effects on the Contractile Machinery of Human Cardiomyocyte Clusters. PLoS One (2015) 0.75

The benefits and risks of stem cell technology. Oral Dis (2011) 0.75

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling. Cardiol Res Pract (2016) 0.75

Scalable Electrophysiological Investigation of iPS Cell-Derived Cardiomyocytes Obtained by a Lentiviral Purification Strategy. J Clin Med (2015) 0.75

RNA interference-based therapeutics for inherited long QT syndrome. Exp Ther Med (2015) 0.75

Modeling human protein aggregation cardiomyopathy using murine induced pluripotent stem cells. Stem Cells Transl Med (2013) 0.75

Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res (2017) 0.75

Murine Electrophysiological Models of Cardiac Arrhythmogenesis. Physiol Rev (2017) 0.75

Articles by these authors

Oct4-induced pluripotency in adult neural stem cells. Cell (2009) 6.50

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med (2004) 4.59

Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature (2007) 3.46

Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A (2002) 3.27

Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei. Cardiovasc Res (2010) 3.00

Potential risks of bone marrow cell transplantation into infarcted hearts. Blood (2007) 2.97

Optogenetic control of heart muscle in vitro and in vivo. Nat Methods (2010) 2.47

Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol (2010) 2.45

c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci U S A (2012) 2.35

Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell (2009) 2.26

Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23

Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol (2008) 2.17

c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci U S A (2009) 2.06

Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron (2006) 1.84

Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol (2006) 1.72

Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation (2013) 1.72

Association with the auxiliary subunit PEX5R/Trip8b controls responsiveness of HCN channels to cAMP and adrenergic stimulation. Neuron (2009) 1.64

The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet (2007) 1.61

Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol (2003) 1.47

Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res (2003) 1.44

Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation. Stem Cells (2015) 1.27

Reduced cardiac L-type Ca2+ current in Ca(V)beta2-/- embryos impairs cardiac development and contraction with secondary defects in vascular maturation. Circ Res (2006) 1.24

Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation (2010) 1.22

Cellular cardiomyoplasty improves survival after myocardial injury. Circulation (2002) 1.21

Intracellular Ca2+ oscillations, a potential pacemaking mechanism in early embryonic heart cells. J Gen Physiol (2007) 1.20

Concise review: The role of C-kit expressing cells in heart repair at the neonatal and adult stage. Stem Cells (2014) 1.12

Activity of complex III of the mitochondrial electron transport chain is essential for early heart muscle cell differentiation. FASEB J (2004) 1.11

Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A (2008) 1.08

Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL. J Immunol (2007) 1.07

Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07

Establishment and characterization of a mouse embryonic heart slice preparation. Cell Physiol Biochem (2005) 1.05

Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension (2003) 1.01

Deletion of the last five C-terminal amino acid residues of connexin43 leads to lethal ventricular arrhythmias in mice without affecting coupling via gap junction channels. Basic Res Cardiol (2013) 1.00

Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed (2005) 0.98

Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle. Nat Commun (2012) 0.98

Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res (2007) 0.95

Functional expression of the Na+/Ca2+ exchanger in the embryonic mouse heart. J Mol Cell Cardiol (2006) 0.94

Cellular cardiomyoplasty in a transgenic mouse model. Transplantation (2002) 0.93

Lack of laminin gamma1 in embryonic stem cell-derived cardiomyocytes causes inhomogeneous electrical spreading despite intact differentiation and function. Stem Cells (2009) 0.93

Microelectrode arrays: a new tool to measure embryonic heart activity. J Electrocardiol (2004) 0.91

Diversity of Ca2+ signaling in developing cardiac cells. Ann N Y Acad Sci (2006) 0.90

Perlecan is critical for heart stability. Cardiovasc Res (2008) 0.90

Quantitation and functional characterization of neural cells derived from ES cells using nestin enhancer-mediated targeting in vitro. J Cell Sci (2002) 0.89

Generation of cardiomyocytes from embryonic stem cells experimental studies. Herz (2002) 0.87

Ca2+ activated K channels-new tools to induce cardiac commitment from pluripotent stem cells in mice and men. Stem Cell Rev (2012) 0.85

Fibroblasts facilitate the engraftment of embryonic stem cell-derived cardiomyocytes on three-dimensional collagen matrices and aggregation in hanging drops. Stem Cells Dev (2010) 0.85

Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells. PLoS One (2013) 0.85

Adult germ line stem cells as a source of functional neurons and glia. Stem Cells (2008) 0.85

Endothelial beta1 integrins regulate sprouting and network formation during vascular development. Development (2010) 0.85

Deletion of integrin linked kinase in endothelial cells results in defective RTK signaling caused by caveolin 1 mislocalization. Development (2013) 0.85

The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. Basic Res Cardiol (2014) 0.85

Modulation of L-type Ca(2+) channel current density and inactivation by beta-adrenergic stimulation during murine cardiac embryogenesis. Basic Res Cardiol (2008) 0.84

Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J Electrocardiol (2004) 0.84

Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci U S A (2013) 0.83

Differentiation of mouse embryonic stem cells into cardiomyocytes via the hanging-drop and mass culture methods. Curr Protoc Stem Cell Biol (2010) 0.83

Neuronal connexin-36 can functionally replace connexin-45 in mouse retina but not in the developing heart. J Cell Sci (2010) 0.83

Optimization of magnetic nanoparticle-assisted lentiviral gene transfer. Pharm Res (2012) 0.82

S100A1 enhances the L-type Ca2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytes. J Biol Chem (2005) 0.82

Influence of endostatin on embryonic vasculo- and angiogenesis. Dev Dyn (2004) 0.82

Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling. Endothelium (2006) 0.82

beta(2)-adrenoceptor antagonist ICI 118,551 decreases pulmonary vascular tone in mice via a G(i/o) protein/nitric oxide-coupled pathway. Hypertension (2009) 0.81

Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction. Microvasc Res (2006) 0.81

Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges. Trends Cardiovasc Med (2012) 0.81

Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival. PLoS One (2013) 0.81

Electrophysiological basis of the first heart beats. Cell Physiol Biochem (2010) 0.80

3D microtissue formation of undifferentiated bone marrow mesenchymal stem cells leads to elevated apoptosis. Tissue Eng Part A (2011) 0.80

Regulation of the Na+/Ca2+ exchanger (NCX) in the murine embryonic heart. Cardiovasc Res (2007) 0.80

Differential role of bFGF and VEGF for vasculogenesis. Cell Physiol Biochem (2002) 0.80

Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling. Stem Cell Rev (2015) 0.79

Enrichment and terminal differentiation of striated muscle progenitors in vitro. Exp Cell Res (2009) 0.79

Transgenic systems for unequivocal identification of cardiac myocyte nuclei and analysis of cardiomyocyte cell cycle status. Basic Res Cardiol (2015) 0.79

Live monitoring of small vessels during development and disease using the flt-1 promoter element. Basic Res Cardiol (2012) 0.79

Regulation of voltage-dependent Ca2+ channels in the early developing heart: role of beta1 integrins. Basic Res Cardiol (2002) 0.79

Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice. J Interv Card Electrophysiol (2010) 0.78

Local gene targeting and cell positioning using magnetic nanoparticles and magnetic tips: comparison of mathematical simulations with experiments. Pharm Res (2011) 0.78

Identification of magnetic nanoparticles for combined positioning and lentiviral transduction of endothelial cells. Pharm Res (2012) 0.78

Regulation of Na+/Ca2+ exchange current in the normal and failing heart. Ann N Y Acad Sci (2007) 0.78

Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations. J Clin Invest (2016) 0.77